3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
5
Breast Neoplasms
3
Neoplasm Metastasis
2
Leukemia, B-Cell
2
Urinary Bladder Neoplasms
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hyperparathyroidism, Primary
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Carcinoma, Renal Cell
1
Carcinoma
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Oxaliplatin
49
Fluorouracil
45
Leucovorin
42
Capecitabine
40
Irinotecan
31
Bevacizumab
31
Radiotherapy
24
Cetuximab
23
Radiation
13
Panitumumab
13
Folfox protocol
10
Surgical Procedures, Operative
9
IFL protocol
8
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
aflibercept
5
Immunohistochemistry
5
Gene Expression Profiling
5
Chemotherapy, Adjuvant
5
Fluorodeoxyglucose F18
4
Floxuridine
4
Celecoxib
4
trifluridine tipiracil drug combination
3
dehydroftorafur
3
XELOX
3
Sorafenib
3
Ramucirumab
3
Neoadjuvant Therapy
3
Erlotinib Hydrochloride
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Rectal Neoplasms
×
Tablets
×
Clear all
No trials found.